<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: Early decline in GFR may reflect progressive <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> in type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, but its predictive value in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is uncertain </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS: In this longitudinal study, GFR was measured serially over approximately 4.0 years in 195 Pima Indians with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Renal function decline (RFD) was defined during this initial period by an average GFR loss ≥3.3%/yr, as defined previously in type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Subsequently, participants were followed for up to 17.8 years to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo>, <z:hpo ids='HP_0011420'>death</z:hpo>, or December 31, 2010, whichever came first </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: RFD prevalence during the initial period was 32% in 68 participants with <z:mpath ids='MPATH_458'>normal</z:mpath> baseline <z:mp ids='MP_0002871'>albuminuria</z:mp> (albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio [ACR] &lt; 30 mg/g), 42% in 88 with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (ACR 30 to &lt;300 mg/g), and 74% in 39 with macroalbuminuria (ACR ≥300 mg/g; P&lt;0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>The cumulative incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> 10 years after the initial period was 41% in those with RFD and 15% in those without (P&lt;0.001); 41 of the 49 ESRD cases (83.7%) occurred in participants who had or developed macroalbuminuria during the initial period </plain></SENT>
<SENT sid="6" pm="."><plain>When adjusted for age, sex, <z:mp ids='MP_0002055'>diabetes</z:mp> duration, and <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> A1c, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> hazard rate was 4.78 times (95% confidence interval, 2.39-9.58) as high in those with RFD as in those without; further adjustment for <z:mp ids='MP_0002871'>albuminuria</z:mp> attenuated this association (hazard ratio, 1.79; 95% confidence interval, 0.82-3.91) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, loss of GFR often occurs before the <z:hpo ids='HP_0003674'>onset</z:hpo> of macroalbuminuria, but a decline predictive of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> is strongly dependent on progression to macroalbuminuria </plain></SENT>
</text></document>